From 2022, Brazil will face more difficulties in expanding its purchases of vaccine doses from the Kovacs consortium created by the World Health Organization.
The Geneva-based body decided at a meeting this week that it would change the rules next week to expand the supply of vaccines to the world’s poorest countries. But for that, it will discourage emerging economies such as Brazil from expanding the purchase of vaccines.
The goal is to prioritize the most vulnerable and create laws that will reduce the number of people participating in vaccine purchases. One-third of the current 190 countries are forecast to drop new orders.
In April 2020, the World Health Organization launched a program to prevent racism in the world. The fund was created with the aim of collecting doses and ensuring dose distribution to poorer countries. Brazil did not join at the start.
When he decided to be part of the project, he received an offer from Kovacs to buy 86 million doses, which would be enough for 20% of the population. Brazil was reluctant to refund or even leave in the middle of the process. The final decision of Palacio do Planalto will buy only 43 million doses, which is the minimum amount set by the organizers.
As dosage shortages became apparent in Brazil, the government began talking to the World Health Organization to assess the possibility of expanding Kovacs’ purchases.
But in a decision this week, it was established that governments wishing to make new purchases would have to make a full order and a full payment before any delivery.
In other words: for countries like Brazil, South Africa, Mexico or Argentina, the new vaccines will have to be fully banked under the reservation law, which will create barriers for governments.
Today, payments are made as doses are released. However, for Kovacs, this means that the financial risk is with the agency. In addition, the situation still prevents the consortium from taking further steps to ensure vaccinations for the 92 poorest countries in the world.
Today, African countries receive only 1.5% of the world’s vaccines. For the World Health Organization, this is a “moral failure” and a new dimension of inequality.